Company intelligence / Profile preview

Myst Therapeutics

Los Angeles, California, United Statesmyst-tx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Myst developed a proprietary T-cell selection strategy for identifying, expanding, and stimulating antigen-reactive T-cells from tumors and peripheral blood

Therapeutic areas: Oncology
Modalities: T-cell therapiesTIL (Tumor Infiltrating Lymphocyte) therapyadoptive cell therapy
Industry: Biotech

Partnerships

Development collaborations mentioned but specific partners not named

Beyond the preview

Go deeper on Myst Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myst Therapeutics.

Explore the full profile